Evidence map›Paper›PMID 27402114›Full record

ArticleBMC complementary and alternative medicine2016

Total dosage of gardenia fruit used by patients with mesenteric phlebosclerosis.

Yutaka Nagata, Tetsuo Watanabe, Kazuhiko Nagasaka, Masaaki Yamada, Masafumi Murai, Sunao Takeuchi, Mai Murase, Toshinori Yazaki, Takayuki Murase, Kenichi Komatsu and 5 more

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 33 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Adverse Effects of Kampo Medicines.Internal medicine (Tokyo, Japan) · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Effects of Long-Term Administration of Gardeniae Fructus on Intra-Abdominal Organs of Rats.Evidence-based complementary and alternative medicine : eCAM · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Yutaka NagataDepartment of Oriental Traditional Medical Center, Suwa Central Hospital, 4300 Tamagawa, Chino, Nagano, 391-8503, Japan. ynagata@suwachuo.jp.
Tetsuo WatanabeDepartment of Japanese Oriental Medicine and Rheumatology, Toyama Prefectural Central Hospital, Toyama, Toyama, Japan.
Kazuhiko NagasakaDepartment of Oriental Traditional Medical Center, Suwa Central Hospital, 4300 Tamagawa, Chino, Nagano, 391-8503, Japan.
Masaaki YamadaDepartment of Epidemiology and Health Policy, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Toyama, Japan.
Masafumi MuraiHokudaimae Clinic, Hokkaido Kampo Medical Center, Sapporo, Hokkaido, Japan.
Sunao TakeuchiDepartment of Internal medicine, Suwa Central Hospital, Chino, Nagano, Japan.
Mai MuraseDepartment of Internal medicine, Suwa Central Hospital, Chino, Nagano, Japan.
Toshinori YazakiDepartment of Internal medicine, Suwa Central Hospital, Chino, Nagano, Japan.
Takayuki MuraseDepartment of Internal medicine, Suwa Central Hospital, Chino, Nagano, Japan.
Kenichi KomatsuDepartment of Surgery, Suwa Central Hospital, Chino, Nagano, Japan.
Machiko KaizukaDepartment of Surgery, Suwa Central Hospital, Chino, Nagano, Japan.
Mika SanoDepartment of Radiology, Suwa Central Hospital, Chino, Nagano, Japan.
Koji AsanoDepartment of Pathology, Suwa Central Hospital, Chino, Nagano, Japan.
Chikao AndoRiver Side Clinic, Chino, Nagano, Japan.
Norihide TaniuchiDepartment of Internal medicine, Suwa Central Hospital, Chino, Nagano, Japan.
Suwa Red Cross Hospital · JPKeiyukai Sapporo Hospital · JPToyama Prefectural Central Hospital · JPUniversity of Toyama · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMesenteric phlebosclerosis (MP) is a disease characterized by fibrotic change or calcification of the mesenteric vein. Recently, there has been an increase in case reports of MP related to herbal medicine usage. Long-term intake of gardenia fruit (GF) is suspected as a possible cause. However, many GF users do not develop this disease and the association between GF and MP remains unclear. In this study, we investigated for the first time the dosage of GF used by patients with and without MP.

methodsWe used a medical chart review study design to assess the association between GF and MP. We reviewed patients with a history of intake of herbal medicines containing GF. Among these patients, we selected patients who were examined by colonoscopy and abdominal plain computed tomography (CT). We investigated the findings of colonoscopy, CT scan and histological examination. We assessed the total dosages of GF alongside the duration of ambulatory visit, the administration period of herbal medicine containing GF and pre-existing disease in order to compare MP cases and non-MP patients.

resultsTen MP cases and 42 non-MP patients were analyzed. We summarized clinical findings of MP cases. All MP cases used more GF than non-MP patients and were administered more than approximately 5,000 grams of GF in cumulative dosage.

conclusionsThis study indicated that excessive intake of GF contributes to and/or accelerates the development of MP suggesting that long-term usage of GF in excessive amounts increases the risk of MP.

Indexed as

AgedFemaleFruitGardeniaHumansMaleMesenteric VeinsMiddle AgedPhytotherapyPlant ExtractsPlants, MedicinalVascular CalcificationPlant ExtractsGardenia fruitHerbal medicineKampoMesenteric phlebosclerosisSanshishi

Identifiers

PMID27402114
PMCPMC4940942
OpenAlexW2461828954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.